Salman Bandeali, MD

See Publications

Texas Heart Institute Positions

Teaching Staff, Cardiovascular Disease Fellowship
Teaching Staff, Interventional Cardiology

Academic & Clinical Affiliations

Texas Heart & Vascular Specialists

Honors, Awards and Memberships

Publications

4862227 Z2Y79GLS 1 alternatives-to-animal-experimentation 10 date desc Bandeali 10263 https://www.texasheart.org/wp-content/plugins/zotpress/

%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y4NVKM9C%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Allencherril%20et%20al.%22%2C%22parsedDate%22%3A%222022-12-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAllencherril%2C%20J.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%2C%20Nikus%2C%20K.%20et%20al.%20%282022%29.%20Acute%20chest%20pain%20in%20a%20patient%20with%20left%20bundle%20branch%20pacing.%20%26lt%3Bi%26gt%3BJ%20Electrocardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B77%26lt%3B%5C%2Fi%26gt%3B%2C%2051%26%23x2013%3B54.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jelectrocard.2022.12.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jelectrocard.2022.12.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20chest%20pain%20in%20a%20patient%20with%20left%20bundle%20branch%20pacing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Allencherril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kjell%22%2C%22lastName%22%3A%22Nikus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yochai%22%2C%22lastName%22%3A%22Birnbaum%22%7D%5D%2C%22abstractNote%22%3A%22We%20present%20a%20patient%20with%20left%20bundle%20branch%20%28LBB%29%20electronic%20ventricular%20pacing%20with%20chest%20pain.%20ECG%20showed%20ventricular%20pacing%20and%20ST%20elevation%20in%20the%20inferolateral%20leads.%20At%20first%20it%20was%20felt%20that%20the%20Sgarbossa%20criteria%20for%20STEMI%20in%20electronic%20ventricular%20pacing%20are%20not%20met.%20However%2C%20as%20symptoms%20persisted%2C%20emergency%20coronary%20angiography%20was%20performed%20showing%20complete%20occlusion%20of%20the%20left%20circumflex%20artery.%20As%20LBB%20pacing%20results%20in%20narrow%20QRS%20complexes%20with%20incomplete%20right%20bundle%20branch%20block%2C%20ST-segment%20deviation%20should%20not%20be%20ignored%20and%20the%20Sgarbossa%20criteria%20for%20patients%20with%20LBB%20block%20or%20right%20ventricular%20electronic%20pacing%20should%20not%20be%20applied.%22%2C%22date%22%3A%222022-12-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jelectrocard.2022.12.006%22%2C%22ISSN%22%3A%221532-8430%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K4H4V8VZ%22%2C%22Z547RX8N%22%2C%22Z2Y79GLS%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-03-07T21%3A49%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22P4MWY5W9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bush%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBush%2C%20A.%20L.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20J.%2C%20Moore%2C%20W.%20et%20al.%20%282021%29.%20Echocardiography%20and%20nuclear%20scintigraphy%20in%20the%20diagnosis%20of%20transthyretin%20cardiac%20amyloidosis.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20e207279.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7279%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-20-7279%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Echocardiography%20and%20nuclear%20scintigraphy%20in%20the%20diagnosis%20of%20transthyretin%20cardiac%20amyloidosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20L.%22%2C%22lastName%22%3A%22Bush%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%20J.%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Warren%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joggy%20K.%22%2C%22lastName%22%3A%22George%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Nov%201%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-20-7279%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223AZ57DW6%22%2C%22USMR7XNI%22%2C%22WS63FIXU%22%2C%22Z2Y79GLS%22%2C%22AUPQENLZ%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A15%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22XNU8WKB6%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khalid%20et%20al.%22%2C%22parsedDate%22%3A%222019-12-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKhalid%2C%20U.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%2C%20Jones%2C%20P.%20G.%20et%20al.%20%282019%29.%20Prescription%20patterns%20of%20clopidogrel%2C%20prasugrel%2C%20and%20ticagrelor%20after%20percutaneous%20coronary%20intervention%20with%20stent%20implantation%20%28from%20the%20NCDR%20PINNACLE%20Registry%29.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B124%26lt%3B%5C%2Fi%26gt%3B%2C%201807%26%23x2013%3B1812.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2019.09.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2019.09.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prescription%20patterns%20of%20clopidogrel%2C%20prasugrel%2C%20and%20ticagrelor%20after%20percutaneous%20coronary%20intervention%20with%20stent%20implantation%20%28from%20the%20NCDR%20PINNACLE%20Registry%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Umair%22%2C%22lastName%22%3A%22Khalid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%20G.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%20S.%22%2C%22lastName%22%3A%22Virani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%22%2C%22lastName%22%3A%22Hira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ihab%22%2C%22lastName%22%3A%22Hamzeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20S.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20S.%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nasser%22%2C%22lastName%22%3A%22Lakkis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%5D%2C%22abstractNote%22%3A%22The%20use%20of%20prasugrel%20and%20ticagrelor%20as%20part%20of%20dual%20antiplatelet%20therapy%20is%20increasing%20in%20patients%20after%20percutaneous%20coronary%20intervention%20%28PCI%29.%20Accordingly%2C%20we%20aimed%20to%20evaluate%20their%20prescription%20patterns%20in%20the%20National%20Cardiovascular%20Data%20Registry%20%28NCDR%29%20Practice%20Innovation%20and%20Clinical%20Excellence%20%28PINNACLE%29%20registry.%20We%20analyzed%20patients%20enrolled%20in%20NCDR%20PINNACLE%20registry%20from%20January%202013%20to%20March%202015%20who%20underwent%20PCI%20with%20drug-eluting%20stent%20and%20were%20prescribed%20dual%20antiplatelet%20therapy.%20All%20patients%20received%20aspirin.%20The%20primary%20study%20outcome%20was%20a%203-level%20variable%20denoting%20the%20second%20antiplatelet%20agent%20prescribed%3A%20%281%29%20clopidogrel%2C%20%282%29%20prasugrel%2C%20or%20%283%29%20ticagrelor.%20Baseline%20characteristics%20were%20compared%20among%20the%203%20groups.%20Odds%20ratios%20and%2095%25%20credible%20intervals%20were%20calculated%20from%20a%20nested%20hierarchical%20Bayesian%20logistic%20regression%20models%20to%20identify%20independent%20predictors%20of%20prescription%20of%20antiplatelet%20medications%2C%20incorporating%20practice%20and%20provider%20as%20random%20effects.%20Our%20study%20cohort%20consisted%20of%2026%2C710%20patients%20during%20our%20study%20period%20January%202013%20to%20March%202015.%20Seventy%20nine%20percent%20of%20patients%20were%20prescribed%20clopidogrel%2C%2012%25%20prasugrel%2C%20and%2011%25%20ticagrelor.%20Patients%20aged%20%5Cu226575%20years%2C%20women%2C%20history%20of%20tobacco%20use%2C%20Peripheral%20Arterial%20Disease%20%28PAD%29%2C%20hypertension%2C%20diabetes%2C%20previous%20vascular%20complication%2C%20heart%20failure%2C%20and%20stroke%5C%2Ftransient%20ischemic%20attack%20were%20more%20likely%20to%20be%20on%20clopidogrel%20than%20prasugrel%20or%20ticagrelor.%20The%20relative%20percentages%20of%20ticagrelor%20and%20prasugrel%20were%20higher%20in%20patients%20with%20history%20of%20myocardial%20infarction%2C%20compared%20with%20those%20without%20myocardial%20infarction.%20In%20summary%2C%20our%20study%20highlights%20the%20prescription%20patterns%20associated%20with%20prescription%20of%20antiplatelet%20agents%20after%20PCI.%20We%20found%20that%20both%20ticagrelor%20and%20prasugrel%20were%20mostly%20prescribed%20per%20the%20current%20practice%20guidelines%2C%20thus%20reflecting%20appropriate%20guideline%20adherence%20by%20practices%20in%20NCDR%20PINNACLE%20registry.%22%2C%22date%22%3A%22Dec%2015%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2019.09.003%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-04-26T13%3A45%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22MCY7KX6Z%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lulla%20et%20al.%22%2C%22parsedDate%22%3A%222013-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLulla%2C%20P.%20D.%2C%20Brammer%2C%20J.%20E.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20et%20al.%20%282013%29.%20Sustained%20complete%20remission%20of%20metastatic%20hepatocellular%20carcinoma%20with%20single%20agent%20sorafenib.%20%26lt%3Bi%26gt%3BJ%20Gastrointest%20Cancer%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B44%26lt%3B%5C%2Fi%26gt%3B%2C%2098%26%23x2013%3B101.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12029-012-9438-6%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12029-012-9438-6%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustained%20complete%20remission%20of%20metastatic%20hepatocellular%20carcinoma%20with%20single%20agent%20sorafenib%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Premal%20D.%22%2C%22lastName%22%3A%22Lulla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20E.%22%2C%22lastName%22%3A%22Brammer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Garret%20R.%22%2C%22lastName%22%3A%22Lynch%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222013-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12029-012-9438-6%22%2C%22ISSN%22%3A%221941-6636%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-01-21T22%3A40%3A00Z%22%7D%7D%2C%7B%22key%22%3A%224WHVHPIG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mehta%20et%20al.%22%2C%22parsedDate%22%3A%222012-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMehta%2C%20N.%2C%20Huang%2C%20H.%20D.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20et%20al.%20%282012%29.%20Prevalence%20of%20acute%20myocardial%20infarction%20in%20patients%20with%20presumably%20new%20left%20bundle-branch%20block.%20%26lt%3Bi%26gt%3BJ%20Electrocardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B45%26lt%3B%5C%2Fi%26gt%3B%2C%20361%26%23x2013%3B367.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jelectrocard.2012.04.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jelectrocard.2012.04.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20of%20acute%20myocardial%20infarction%20in%20patients%20with%20presumably%20new%20left%20bundle-branch%20block%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilay%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henry%20D.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yochai%22%2C%22lastName%22%3A%22Birnbaum%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20We%20assessed%20the%20prevalence%20of%20true%20acute%20myocardial%20infarction%20and%20the%20need%20for%20emergent%20revascularization%20among%20patients%20with%20new%20or%20presumably%20new%20left%20bundle%20branch%20block%20%28nLBBB%29%20for%20whom%20the%20primary%20percutaneous%20coronary%20intervention%20protocol%20was%20activated.%5CnMETHODS%20AND%20RESULTS%3A%20Among%20802%20patients%2C%2069%20%288.6%25%29%20had%20nLBBB.%20The%20chief%20presenting%20symptom%20was%20chest%20pain%20or%20cardiac%20arrest%20in%2036%20patients%20%2852.2%25%29%20and%20shortness%20of%20breath%20in%2015%20%2821.7%25%29.%20Less%20than%2030%25%20of%20the%20patients%20had%20elevated%20cardiac%20troponin-I%2C%20and%20less%20than%2010%25%20had%20elevated%20creatine%20kinase-MB.%20Only%2011.6%25%20of%20the%20patients%20underwent%20emergent%20revascularization%3B%20the%20rate%20was%20higher%20for%20patients%20who%20presented%20with%20chest%20pain%20or%20cardiac%20arrest%20or%20shortness%20of%20breath%20than%20for%20patients%20who%20presented%20with%20other%20symptoms.%5CnCONCLUSIONS%3A%20Acute%20myocardial%20infarction%20and%20the%20need%20for%20emergent%20revascularization%20are%20relatively%20uncommon%20among%20patients%20who%20present%20with%20nLBBB%2C%20especially%20when%20symptoms%20are%20atypical.%20Current%20guidelines%20for%20primary%20percutaneous%20coronary%20intervention%20protocol%20activation%20for%20nLBBB%20should%20be%20reconsidered.%22%2C%22date%22%3A%222012%20Jul-Aug%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jelectrocard.2012.04.006%22%2C%22ISSN%22%3A%221532-8430%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K4H4V8VZ%22%2C%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222021-08-21T15%3A34%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22ABS292NC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kayani%20et%20al.%22%2C%22parsedDate%22%3A%222012-04-28%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKayani%2C%20W.%20T.%2C%20Huang%2C%20H.%20D.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20et%20al.%20%282012%29.%20ST%20elevation%3A%20telling%20pathology%20from%20the%20benign%20patterns.%20%26lt%3Bi%26gt%3BGlob%20J%20Health%20Sci%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B4%26lt%3B%5C%2Fi%26gt%3B%2C%2051%26%23x2013%3B63.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5539%5C%2Fgjhs.v4n3p51%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5539%5C%2Fgjhs.v4n3p51%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ST%20elevation%3A%20telling%20pathology%20from%20the%20benign%20patterns%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Waleed%20Tallat%22%2C%22lastName%22%3A%22Kayani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henry%20D.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%20S.%22%2C%22lastName%22%3A%22Virani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yochai%22%2C%22lastName%22%3A%22Birnbaum%22%7D%5D%2C%22abstractNote%22%3A%22Benefits%20of%20early%20reperfusion%20in%20patients%20presenting%20with%20acute%20ST%20elevation%20myocardial%20infarction%20%28STEMI%29%20are%20well%20known.%20The%20American%20College%20of%20Cardiology%20%5C%2F%20American%20Heart%20Association%20guidelines%20recommend%20triage%20decisions%20are%20made%20within%2010%20minutes%20of%20performing%20initial%20electrocardiogram%20%28ECG%29.%20Since%20many%20patients%20presenting%20with%20ischemic%20symptoms%20may%20have%20ST%20elevation%20%28STE%29%20at%20baseline%2C%20not%20all%20STE%20signify%20transmural%20ischemia.%20Benign%20patterns%20can%20be%20easy%20to%20find%20in%20some%20cases.%20However%2C%20patients%20with%20benign%20STE%20at%20baseline%20%28left%20ventricular%20hypertrophy%2C%20early%20repolarization%20pattern%29%20may%20have%20ongoing%20ischemia%20and%20present%20with%20Non-ST%20elevation%20myocardial%20infarction%20%28NSTEMI%29%20or%20even%20STEMI%20superimposed%20on%20the%20benign%20pattern.%20The%20ability%20of%20clinicians%20to%20distinguish%20between%20ischemic%20and%20non%20ischemic%20STE%20varies%20widely%20and%20is%20affected%20by%20prevalence%20of%20such%20changes%20in%20patient%20population.%20More%20studies%20need%20to%20be%20done%20to%20delineate%20the%20criteria%20to%20clearly%20distinguish%20between%20ischemic%20and%20non%20ischemic%20ST%20elevation.%22%2C%22date%22%3A%22Apr%2028%2C%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5539%5C%2Fgjhs.v4n3p51%22%2C%22ISSN%22%3A%221916-9736%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K4H4V8VZ%22%2C%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222021-08-21T15%3A34%3A19Z%22%7D%7D%2C%7B%22key%22%3A%225PR45C32%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bandeali%20and%20Farmer%22%2C%22parsedDate%22%3A%222012-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20and%20Farmer%2C%20J.%20%282012%29.%20High-density%20lipoprotein%20and%20atherosclerosis%3A%20the%20role%20of%20antioxidant%20activity.%20%26lt%3Bi%26gt%3BCurr%20Atheroscler%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20101%26%23x2013%3B107.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11883-012-0235-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11883-012-0235-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High-density%20lipoprotein%20and%20atherosclerosis%3A%20the%20role%20of%20antioxidant%20activity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Farmer%22%7D%5D%2C%22abstractNote%22%3A%22Levels%20of%20high-density%20lipoprotein%20%28HDL%29%20cholesterol%20are%20generally%20inversely%20associated%20with%20the%20risk%20for%20the%20development%20of%20atherosclerosis.%20The%20mechanism%20by%20which%20HDL%20imparts%20protection%20from%20the%20initiation%20and%20progression%20of%20occlusive%20vascular%20disease%20is%20complex%20and%20multifactorial.%20The%20major%20anti-atherosclerotic%20effect%20of%20HDL%20is%20felt%20to%20be%20reverse%20cholesterol%20transport.%20HDL%20has%20been%20demonstrated%20to%20scavenge%20cholesterol%20from%20the%20peripheral%20vasculature%20with%20transport%20to%20the%20liver%2C%20where%20is%20it%20excreted%20in%20the%20biliary%20system.%20However%2C%20HDL%20exhibits%20multiple%20other%20physiologic%20effects%20that%20may%20play%20a%20role%20in%20the%20reduced%20risk%20for%20atherosclerosis.%20HDL%20has%20been%20demonstrated%20to%20exhibit%20beneficial%20effects%20on%20platelet%20function%2C%20endothelial%20function%2C%20coagulation%20parameters%2C%20inflammation%2C%20and%20interactions%20with%20triglyceride-rich%20lipoproteins.%20Increasing%20amounts%20of%20clinical%20and%20experimental%20data%20have%20shown%20that%20HDL%20cholesterol%20has%20significant%20antioxidant%20effect%20that%20may%20significantly%20contribute%20to%20protection%20from%20atherosclerosis.%22%2C%22date%22%3A%222012-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11883-012-0235-2%22%2C%22ISSN%22%3A%221534-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222021-08-21T15%3A22%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22XY5IHX2F%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lulla%20et%20al.%22%2C%22parsedDate%22%3A%222011-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLulla%2C%20P.%2C%20%26lt%3Bstrong%26gt%3BBandeali%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20and%20Baker%2C%20K.%20%282011%29.%20Fatal%20paraneoplastic%20systemic%20leukocytoclastic%20vasculitis%20as%20a%20presenting%20feature%20of%20chronic%20lymphocytic%20leukemia.%20%26lt%3Bi%26gt%3BClin%20Lymphoma%20Myeloma%20Leuk%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B11%20Suppl%201%26lt%3B%5C%2Fi%26gt%3B%2C%20S14-16.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.clml.2011.03.030%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.clml.2011.03.030%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fatal%20paraneoplastic%20systemic%20leukocytoclastic%20vasculitis%20as%20a%20presenting%20feature%20of%20chronic%20lymphocytic%20leukemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Premal%22%2C%22lastName%22%3A%22Lulla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salman%22%2C%22lastName%22%3A%22Bandeali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelty%22%2C%22lastName%22%3A%22Baker%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20most%20common%20paraneoplastic%20vasculitis%20is%20leukocytoclastic%20vasculitis%20%28LCV%29%2C%281%29%2075%25%20of%20which%20are%20caused%20by%20hematological%20malignancies.%20Chronic%20lymphocytic%20leukemia%20%28CLL%29%20is%20associated%20with%20a%20multitude%20of%20auto-immune%20paraneoplastic%20syndromes.%20Data%20on%20LCV%20in%20association%20with%20CLL%20is%20restricted%20to%20isolated%20case%20reports%2C%283%2C4%29%20none%20of%20which%20had%20systemic%20LCV.%20We%20present%20a%20unique%20case%20of%20fatal%20paraneoplastic%2C%20systemic%20LCV%20as%20an%20initial%20presentation%20of%20CLL%20in%20an%20elderly%20male%20with%20multiple%20co-morbidities.%5CnCASE%3A%20A%2071-year-old%20man%20presented%20with%20a%20palpable%2C%20symmetric%2C%20purpuric%20rash%20on%20the%20lower%20extremities%20and%20an%20absolute%20lymphocytosis%20%28white%20blood%20cell%20count%2026.9%3B%2023%25%20lymphocytes%29.%20His%20co-morbidities%20included%20coronary%20artery%20disease%2C%20congestive%20heart%20failure%2C%20and%20new%20critical%20aortic%20stenosis.%20Flow%20cytometry%20of%20peripheral%20blood%20demonstrated%20an%20abnormal%20population%20of%20B-cells%2C%20positive%20for%20CD5%2C%20CD19%2C%20and%20CD23%2C%20consistent%20with%20CLL.%20The%20skin%20biopsy%20specimen%20revealed%20neutrophilic%20inflammation%20in%20vessel%20walls%20indicative%20of%20LCV.%20Acute%20renal%20failure%20%28creatinine%202%20mg%5C%2FdL%29%2C%20urinary%20red%20cell%20casts%2C%20and%20hypocomplementemia%20were%20concerning%20for%20a%20systemic%20vasculitis.%20The%20antinuclear%20antibody%2C%20cryoglobulin%20titer%2C%20antineutrophil%20cytoplasmic%20antibody%2C%20serum%20protein%20electrophoresis%2C%20viral%20serologies%20were%20negative.%20On%20hospital%20day%206%2C%20he%20developed%20acute%20hepatocellular%20injury%20and%20acute%20respiratory%20failure.%20Continuous%20veno-venous%20hemodialysis%20was%20begun%20for%20worsening%20acidemia%20and%20hyperkalemia.%20Two%20days%20later%20he%20became%20obtunded%20on%20hospital%20day%208%20and%20had%20an%20elevated%20lactic%20acid%20level%20with%20generalized%20abdominal%20tenderness%20worrisome%20for%20bowel%20ischemia.%20The%20same%20day%20he%20needed%20intubation%20with%20cardiopulmonary%20resuscitation%20for%20a%20brief%20episode%20of%20asystole.%20Despite%20aggressive%20treatment%20with%20high-dose%20steroids%20and%20plasmapheresis%2C%20he%20suffered%20worsening%20renal%20failure%20and%20shock.%20His%20family%20sought%20withdrawal%20of%20care%20on%20hospital%20day%2011.%20Autopsy%20revealed%20diffuse%20LCV%20of%20the%20stomach%2C%20distal%20ileum%2C%20integument%20and%20alveoli%20with%20petechial%20hemorrhages%2C%20fibrin%20thrombi%2C%20and%20gangrenous%20patchy%20necrosis.%5CnCONCLUSION%3A%20Paraneoplastic%20LCV%20is%20a%20rare%20syndrome%20and%20seldom%20occurs%20in%20association%20with%20CLL.%20This%20is%20the%20first%20reported%20case%20of%20fatal%20systemic%20paraneoplastic%20LCV%20from%20B-cell%20CLL.%20Dermatologic%20involvement%20is%20universal%20with%20LCV%2C%20and%20may%20portend%20systemic%20disease.%20More%20data%20on%20its%20pathogenesis%20in%20CLL%20is%20warranted.%22%2C%22date%22%3A%222011-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.clml.2011.03.030%22%2C%22ISSN%22%3A%222152-2669%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22Z2Y79GLS%22%2C%22X2D36SJL%22%5D%2C%22dateModified%22%3A%222022-01-21T22%3A41%3A02Z%22%7D%7D%5D%7D

Allencherril, J., Bandeali, S., Nikus, K. et al. (2022). Acute chest pain in a patient with left bundle branch pacing. J Electrocardiol 77, 51–54. https://doi.org/10.1016/j.jelectrocard.2022.12.006.

Bush, A. L., Bandeali, S. J., Moore, W. et al. (2021). Echocardiography and nuclear scintigraphy in the diagnosis of transthyretin cardiac amyloidosis. Tex Heart Inst J 48, e207279. https://doi.org/10.14503/THIJ-20-7279.

Khalid, U., Bandeali, S., Jones, P. G. et al. (2019). Prescription patterns of clopidogrel, prasugrel, and ticagrelor after percutaneous coronary intervention with stent implantation (from the NCDR PINNACLE Registry). Am J Cardiol 124, 1807–1812. https://doi.org/10.1016/j.amjcard.2019.09.003.

Lulla, P. D., Brammer, J. E., Bandeali, S. et al. (2013). Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib. J Gastrointest Cancer 44, 98–101. https://doi.org/10.1007/s12029-012-9438-6.

Mehta, N., Huang, H. D., Bandeali, S. et al. (2012). Prevalence of acute myocardial infarction in patients with presumably new left bundle-branch block. J Electrocardiol 45, 361–367. https://doi.org/10.1016/j.jelectrocard.2012.04.006.

Kayani, W. T., Huang, H. D., Bandeali, S. et al. (2012). ST elevation: telling pathology from the benign patterns. Glob J Health Sci 4, 51–63. https://doi.org/10.5539/gjhs.v4n3p51.

Bandeali, S. and Farmer, J. (2012). High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep 14, 101–107. https://doi.org/10.1007/s11883-012-0235-2.

Lulla, P., Bandeali, S. and Baker, K. (2011). Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 11 Suppl 1, S14-16. https://doi.org/10.1016/j.clml.2011.03.030.